About
Matthew R. Patterson is a Venture Partner at SR One Capital Management with over 30 years in the research, development, and commercialization of therapeutics. He co-founded Audentes Therapeutics in 2012 and served as its CEO until its 2020 acquisition by Astellas Pharma, and previously worked at Genzyme, BioMarin Pharmaceutical, Amicus Therapeutics, and Iris Medicine, as well as serving as an Entrepreneur-In-Residence at OrbiMed. He holds a Bachelor's degree in Biochemistry from Bowdoin College.
Invests in
Biotech
Investments
Board seats
Addition TherapeuticsAddition Therapeutics, Inc.Remix Therapeutics, Inc.Vor Biopharma, Inc.
Sources: the firm's website · SEC Form D filings.
Colleagues at SR One Capital Management
Alicia Hasson
Executive Assistant at SR One Capital Management
Amit Mehta
Venture Partner - US Investments at SR One Capital Management
Amit Shah
Principal at SR One Capital Management
Ann Ng
Finance Director at SR One Capital Management
Brian Gallagher
Partner at SR One Capital Management
Briana Wilson
Senior Administrative Assistant at SR One Capital Management
Catalina Kazi
Legal & Compliance Counsel at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management